E2F and MYC targets, mTORC1 signaling, P53 pathway, and KRAS signal gene sets were significantly upregulated in resistant breast cancer cells (Supplementary Figure S2), suggesting that chemoresistance of breast cancer cells might be closely related to the regulation of the cell cycle and apoptosis. The gene discussed is TP53; the disease is breast carcinoma.